Cargando…
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
The metabolites produced by the gut microbiota have been reported as crucial agents against obesity; however, their key targets have not been revealed completely in complex microbiome systems. Hence, the aim of this study was to decipher promising prebiotics, probiotics, postbiotics, and more import...
Autores principales: | Oh, Ki-Kwang, Gupta, Haripriya, Min, Byeong-Hyun, Ganesan, Raja, Sharma, Satya Priya, Won, Sung-Min, Jeong, Jin-Ju, Lee, Su-Been, Cha, Min-Gi, Kwon, Goo-Hyun, Jeong, Min-Kyo, Hyun, Ji-Ye, Eom, Jung-A, Park, Hee-Jin, Yoon, Sang-Jun, Choi, Mi-Ran, Kim, Dong Joon, Suk, Ki-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496669/ https://www.ncbi.nlm.nih.gov/pubmed/36139478 http://dx.doi.org/10.3390/cells11182903 |
Ejemplares similares
-
Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
The Lactobacillus as a Probiotic: Focusing on Liver Diseases
por: Jeong, Jin-Ju, et al.
Publicado: (2022) -
The Link between Gut Microbiota and Hepatic Encephalopathy
por: Won, Sung-Min, et al.
Publicado: (2022) -
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023) -
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)